Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

IMA402, an Off-the-Shelf, Next-Generation TCR Bispecific (TCER®) for Efficiently Targeting an HLA-Presented Peptide from the Pan-Cancer Antigen PRAME

Sebastian Bunk, Martin Hofmann, Gabriele Pszolla, Meike Hutt, Frank Schwöbel, Felix Unverdorben, Nadine Aschmoneit, Claudia Wagner, Maike Jaworski, Heiko Schuster, Florian Schwoerer, Christoph Schraeder, Oliver Schoor, Sarah Missel, Toni Weinschenk, Dominik Maurer, Carsten Reinhardt

Blood (2022) 140 (Supplement 1): 9089–9090.

https://doi.org/10.1182/blood-2022-165937

Published: 2022

Journal Articles

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

Sebastian Bunk, PhD, Martin Hofmann, PhD, Felix Unverdorben, PhD, Meike Hutt, PhD, Gabriele Pszolla, PhD, Frank Schwöbel, PhD, Claudia Wagner, PhD, Sara Yousef, PhD, Heiko Schuster, PhD, Sarah Missel, PhD, Oliver Schoor, PhD, Toni Weinschenk, PhD, Harpreet Singh-Jasuja, PhD, Dominik Maurer, PhD, Carsten Reinhardt, MD

Blood (2019) 134 (Supplement_1): 3368.

https://doi.org/10.1182/blood-2019-129958

Published: 2019

Journal Articles

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Blood (2019) 133 (6): 550–565.

https://doi.org/10.1182/blood-2018-07-866830

Published: 2019

Includes: Supplemental data

Journal Articles

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

Blood (2018) 132 (Supplement 1): 4243.

https://doi.org/10.1182/blood-2018-99-113376

Published: 2018

Journal Articles

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

Annika Nelde, Daniel J. Kowalewski, Linus Backert, Heiko Schuster, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 3234.

https://doi.org/10.1182/blood.V128.22.3234.3234

Published: 2016

Journal Articles

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

Annika Nelde, Heiko Schuster, Daniel J. Kowalewski, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 4046.

https://doi.org/10.1182/blood.V128.22.4046.4046

Published: 2016

Journal Articles

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Linus Backert, Daniel J. Kowalewski, Simon D. Walz, Heiko Schuster, Claudia Berlin, Mirle Schemionek, PhD, Tim H. Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Lothar Kanz, MD, Helmut R. Salih, MD, Katja Weisel, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2016) 128 (22): 2169.

https://doi.org/10.1182/blood.V128.22.2169.2169

Published: 2016

Journal Articles

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Daniel Johannes Kowalewski, Simon D. Walz, Linus Backert, Heiko Schuster, Susanne M. Rittig, MD, Katja C. Weisel, Helmut R Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S Stickel, MD

Blood (2015) 126 (23): 3001.

https://doi.org/10.1182/blood.V126.23.3001.3001

Published: 2015

Journal Articles

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

Juliane S Stickel, MD, Daniel Johannes Kowalewski, Heiko Schuster, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD

Blood (2015) 126 (23): 1722.

https://doi.org/10.1182/blood.V126.23.1722.1722

Published: 2015

Journal Articles

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Simon Walz, Juliane S. Stickel, Daniel Johannes Kowalewski, Heiko Schuster, Katja Weisel, Linus Backert, Stefan Kahn, Annika Nelde, Tatjana Stroh, Martin Handel, Oliver Kohlbacher, Lothar Kanz, Helmut Rainer Salih, Hans-Georg Rammensee, Stefan Stevanović

Blood (2015) 126 (10): 1203–1213.

https://doi.org/10.1182/blood-2015-04-640532

Published: 2015

Includes: Supplemental data

Journal Articles

HLA Ligandome Analysis in Multiple Myeloma Reveals Novel Naturally Presented Myeloma-Associated Antigens Showing Stable Expression Under Proteasome Inhibitor Therapy

Simon D. Walz, Daniel J. Kowalewski, Heiko Schuster, Katja Weisel, MD, Helmut R. Salih, MD, Lothar Kanz, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 3438.

https://doi.org/10.1182/blood.V124.21.3438.3438

Published: 2014

Journal Articles

HLA Ligandome Profiling Identifies a Novel Category of Pathophysiologically Relevant CLL Associated Antigens

Daniel J. Kowalewski, Heiko Schuster, Claudia Berlin, Stefan Kahn, Linus Backert, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, PhD, Stefan Stevanovic, PhD, Juliane S. Stickel, MD

Blood (2014) 124 (21): 715.

https://doi.org/10.1182/blood.V124.21.715.715

Published: 2014

Journal Articles

HLA Class I Ligandome Analysis In Acute Myeloid Leukemia – Novel T-Cell Epitopes For Peptide-Based Immunotherapy

Stickel S. Juliane, Claudia Berlin, Daniel J. Kowalewski, Heiko Schuster, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic

Blood (2013) 122 (21): 5431.

https://doi.org/10.1182/blood.V122.21.5431.5431

Published: 2013

Journal Articles

Mapping The HLA Ligandome Of Chronic Lymphocytic Leukemia – Towards Peptide Based Immunotherapy

Daniel J. Kowalewski, Heiko Schuster, Claudia Berlin, Lothar Kanz, MD, Helmut R. Salih, MD, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Stickel

Blood (2013) 122 (21): 4123.

https://doi.org/10.1182/blood.V122.21.4123.4123

Published: 2013

Journal Articles

HLA Ligandome Analysis of Acute Myeloid Leukemia (AML) Revealed Novel Tumor-Associated Antigens for Immunotherapy.

Juliane Sarah Stickel, MD, Claudia Berlin, Daniel Johannes Kowalewski, Heiko Schuster, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, Prof., Stefan Stevanovic, PhD

Blood (2012) 120 (21): 3012.

https://doi.org/10.1182/blood.V120.21.3012.3012

Published: 2012

Journal Articles

Identification of Novel Tumor-Associated Antigens for Chronic Lymphocytic Leukemia (CLL) Based On HLA Ligandome Analysis – New Targets for Peptide Based Immunotherapy

Daniel Johannes Kowalewski, Heiko Schuster, Claudia Berlin, Lothar Kanz, MD, Helmut R Salih, MD, Hans-Georg Rammensee, Prof., Stefan Stevanovic, PhD, Juliane Sarah Stickel, MD

Blood (2012) 120 (21): 4119.

https://doi.org/10.1182/blood.V120.21.4119.4119

Published: 2012

NARROW

IMA402, an Off-the-Shelf, Next-Generation TCR Bispecific (TCER®) for Efficiently Targeting an HLA-Presented Peptide from the Pan-Cancer Antigen PRAME

Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER ® ) Molecules

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under In Vitro Lenalidomide Treatment Confirms Lenalidomide as a Suitable Combination Partner for T-Cell Based Immunotherapy

Identification of Naturally Presented HLA Ligands of Enriched Leukemic Progenitor Cells for Peptide-Based Immunotherapy in Acute Myeloid Leukemia (AML)

HLA Ligandome Analysis of Different Hematological Malignancies Identifies a Small Panel of "Pan-Leukemia"-Associated Antigens

Mapping the Impact of Proteasome Inhibitor Therapy on the Immunopeptidome of Multiple Myeloma: Mass Spectrometry Identifies Robust Targets for T Cell Immunotherapy

Favorable Immune Signature in CLL Patients, Defined By Antigen-Specific T-Cell Responses, Might Prevent Secondary Skin Cancers

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

HLA Ligandome Analysis in Multiple Myeloma Reveals Novel Naturally Presented Myeloma-Associated Antigens Showing Stable Expression Under Proteasome Inhibitor Therapy

HLA Ligandome Profiling Identifies a Novel Category of Pathophysiologically Relevant CLL Associated Antigens

HLA Class I Ligandome Analysis In Acute Myeloid Leukemia – Novel T-Cell Epitopes For Peptide-Based Immunotherapy

Mapping The HLA Ligandome Of Chronic Lymphocytic Leukemia – Towards Peptide Based Immunotherapy

HLA Ligandome Analysis of Acute Myeloid Leukemia (AML) Revealed Novel Tumor-Associated Antigens for Immunotherapy.

Identification of Novel Tumor-Associated Antigens for Chronic Lymphocytic Leukemia (CLL) Based On HLA Ligandome Analysis – New Targets for Peptide Based Immunotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only